SCHEMBL6475335

SCHEMBL6475335

NC(=O)c1cnn(-c2ccc(Cl)cc2Cl)c1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.52
TSHR P16473 1/20 0.51
SCN9A Q15858 3/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 3/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CNR1 P21554 7/20 0.48
CNR2 P34972 2/20 0.48
FGFR1 P11362 1/20 0.46
SRC P12931 1/20 0.46
FGFR2 P21802 1/20 0.46
FGFR4 P22455 1/20 0.46
FGFR3 P22607 1/20 0.46
KDR P35968 1/20 0.46
ALOX12 P18054 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SCN5A Q14524 1/20 0.44
HTT P42858 1/20 0.43
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1691801 0.89 RIPK2 (0.52) RIPK2TSHRSCN9ALMNARAB9A
SCHEMBL8044057 0.86 RIPK2 (0.50) RIPK2TSHRSCN9ALMNARAB9A
SCHEMBL11039372 0.84 SCN9A (0.52) SCN9AALDH1A1LMNARAB9ACNR1
SCHEMBL8049323 0.83 SCN9A (0.54) RIPK2TSHRSCN9ALMNARAB9A
SCHEMBL8047290 0.83 RIPK2 (0.50) RIPK2TSHRSCN9ALMNARAB9A
SCHEMBL1691442 0.82 RIPK2 (0.63) RIPK2TSHRSCN9AALDH1A1LMNA
SCHEMBL10850115 0.81 ALDH1A1 (0.46) ALDH1A1LMNARAB9ASMN1; SMN2CNR1
SCHEMBL31117084 0.81 HTT (0.69) TSHRSCN9AALDH1A1LMNARAB9A
SCHEMBL6476731 0.81 MAPK1 (0.56) RIPK2TSHRLMNARAB9ASMN1; SMN2
SCHEMBL10340615 0.81 ALDH1A1 (0.48) TSHRALDH1A1LMNASMN1; SMN2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209251-A1 Substituted pyrazolo-pyrimidine-4-ones BAYER CROPSCIENCE AG (DE) 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209251-A1 Substituted pyrazolo-pyrimidine-4-ones P2RX4, DHFR, DDT RIPK2 3879/4885TSHR 848/4885SCN9A 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.